Eating Disorder Inventory-3 (EDI-3) Professional Manual (PAR, 2004)
rather, it reactivates the known vulnerability of SGAs by undermining the assumption of gastric emptiness
Its also possible that people taking GLP-1s were doing other things that lowered their risk of severe migraines, says Dharti Dua, MD, neurologist and clinical assistant professor at The Ohio State University Wexner Medical Center and College of Medicine
Tirzepatide versus dulaglutide in type 2 diabetes: A randomised, phase 2 trial
GLP-1 Medications You May Hear About You may recognize some of these brand names: Wegovy (semaglutide) approved for weight management Saxenda (liraglutide) approved for weight management Zepbound (tirzepatide) approved for weight management Ozempic (semaglutide) approved for Type 2 diabetes
Wegovy is the first once-weekly GLP-1 receptor agonist approved as a weight loss medication for people under the age of 18